vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and MACH NATURAL RESOURCES LP (MNR). Click either name above to swap in a different company.

MACH NATURAL RESOURCES LP is the larger business by last-quarter revenue ($387.5M vs $270.8M, roughly 1.4× HUTCHMED (China) Ltd). MACH NATURAL RESOURCES LP runs the higher net margin — 18.9% vs 0.7%, a 18.1% gap on every dollar of revenue. On growth, MACH NATURAL RESOURCES LP posted the faster year-over-year revenue change (65.0% vs -16.5%).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Mach Natural Resources LP is a US-based upstream energy enterprise focused on the exploration, development, and production of oil, natural gas, and natural gas liquids. Its core operations are located in onshore US hydrocarbon basins including the Permian Basin, prioritizing low-cost, high-yield assets to drive sustainable returns for stakeholders.

HCM vs MNR — Head-to-Head

Bigger by revenue
MNR
MNR
1.4× larger
MNR
$387.5M
$270.8M
HCM
Growing faster (revenue YoY)
MNR
MNR
+81.5% gap
MNR
65.0%
-16.5%
HCM
Higher net margin
MNR
MNR
18.1% more per $
MNR
18.9%
0.7%
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
MNR
MNR
Revenue
$270.8M
$387.5M
Net Profit
$2.0M
$73.1M
Gross Margin
37.7%
Operating Margin
-13.2%
26.1%
Net Margin
0.7%
18.9%
Revenue YoY
-16.5%
65.0%
Net Profit YoY
-83.6%
100.2%
EPS (diluted)
$0.00
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
MNR
MNR
Q4 25
$270.8M
$387.5M
Q3 25
$272.6M
Q2 25
$277.7M
$288.5M
Q1 25
$324.5M
$226.8M
Q4 24
$234.9M
Q3 24
$255.5M
Q2 24
$305.7M
$240.0M
Q1 24
$239.2M
Net Profit
HCM
HCM
MNR
MNR
Q4 25
$2.0M
$73.1M
Q3 25
$-35.7M
Q2 25
$455.0M
$89.7M
Q1 25
$11.9M
$15.9M
Q4 24
$36.5M
Q3 24
$67.4M
Q2 24
$25.8M
$39.5M
Q1 24
$41.7M
Gross Margin
HCM
HCM
MNR
MNR
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
MNR
MNR
Q4 25
-13.2%
26.1%
Q3 25
-7.0%
Q2 25
-1.3%
38.6%
Q1 25
-5.0%
22.8%
Q4 24
24.9%
Q3 24
37.1%
Q2 24
-9.0%
29.4%
Q1 24
28.1%
Net Margin
HCM
HCM
MNR
MNR
Q4 25
0.7%
18.9%
Q3 25
-13.1%
Q2 25
163.8%
31.1%
Q1 25
3.7%
7.0%
Q4 24
15.5%
Q3 24
26.4%
Q2 24
8.4%
16.5%
Q1 24
17.4%
EPS (diluted)
HCM
HCM
MNR
MNR
Q4 25
$0.00
$0.47
Q3 25
$-0.28
Q2 25
$0.52
$0.76
Q1 25
$0.01
$0.14
Q4 24
$0.34
Q3 24
$0.70
Q2 24
$0.03
$0.42
Q1 24
$0.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
MNR
MNR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$42.6M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
Total Assets
$1.8B
$3.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
MNR
MNR
Q4 25
$1.4B
$42.6M
Q3 25
$53.6M
Q2 25
$1.4B
$13.8M
Q1 25
$836.1M
$7.8M
Q4 24
$105.8M
Q3 24
$184.5M
Q2 24
$802.5M
$144.6M
Q1 24
$151.3M
Total Debt
HCM
HCM
MNR
MNR
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
MNR
MNR
Q4 25
$1.2B
Q3 25
Q2 25
$1.2B
Q1 25
$759.9M
Q4 24
Q3 24
Q2 24
$740.1M
Q1 24
Total Assets
HCM
HCM
MNR
MNR
Q4 25
$1.8B
$3.8B
Q3 25
$3.8B
Q2 25
$1.8B
$2.3B
Q1 25
$1.3B
$2.2B
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$1.3B
$2.2B
Q1 24
$2.3B
Debt / Equity
HCM
HCM
MNR
MNR
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
MNR
MNR
Operating Cash FlowLast quarter
$8.2M
$128.7M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
1.76×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
MNR
MNR
Q4 25
$8.2M
$128.7M
Q3 25
$105.5M
Q2 25
$-72.9M
$130.1M
Q1 25
$40.3M
$142.5M
Q4 24
$133.7M
Q3 24
$110.8M
Q2 24
$-39.8M
$116.8M
Q1 24
$144.0M
Free Cash Flow
HCM
HCM
MNR
MNR
Q4 25
$3.4M
Q3 25
Q2 25
$-82.2M
Q1 25
$32.5M
Q4 24
Q3 24
Q2 24
$-49.9M
Q1 24
FCF Margin
HCM
HCM
MNR
MNR
Q4 25
1.2%
Q3 25
Q2 25
-29.6%
Q1 25
10.0%
Q4 24
Q3 24
Q2 24
-16.3%
Q1 24
Capex Intensity
HCM
HCM
MNR
MNR
Q4 25
1.8%
Q3 25
Q2 25
3.3%
Q1 25
2.4%
Q4 24
Q3 24
Q2 24
3.3%
Q1 24
Cash Conversion
HCM
HCM
MNR
MNR
Q4 25
4.21×
1.76×
Q3 25
Q2 25
-0.16×
1.45×
Q1 25
3.38×
8.97×
Q4 24
3.66×
Q3 24
1.64×
Q2 24
-1.54×
2.96×
Q1 24
3.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

MNR
MNR

Oil Gas And Natural Gas Liquids Net$331.0M85%
Natural Gas Liquids Reserves$44.8M12%
Natural Gas Midstream$8.6M2%
Products$6.3M2%

Related Comparisons